Ignite Creation Date:
2024-05-05 @ 9:25 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00881816
Status:
UNKNOWN
Last Update Posted:
2009-04-15
First Post:
2009-04-14
Brief Title:
Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma
Sponsor:
Nanjing Sike Pharmaceutical Co Ltd
Organization:
Nanjing Sike Pharmaceutical Co Ltd
Organization Data
Organization:
Nanjing Sike Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
LPS-GC-02-2008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanjing Sike Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Dr Li Jin
Old Organization:
Cancer Hospital of Fudan University